AFG
Albion Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Hold |
1,113
| – | – | 0.03% | 134 |
|
|
2025
Q1 | $540K | Sell |
1,113
-227
| -17% | -$110K | 0.04% | 142 |
|
|
2024
Q4 | $540K | Buy |
1,340
+42
| +3% | +$16.9K | 0.04% | 141 |
|
|
2024
Q3 | $604K | Sell |
1,298
-22
| -2% | -$10.2K | 0.04% | 134 |
|
|
2024
Q2 | $619K | Sell |
1,320
-75
| -5% | -$35.2K | 0.05% | 129 |
|
|
2024
Q1 | $583K | Buy |
1,395
+57
| +4% | +$23.8K | 0.05% | 131 |
|
|
2023
Q4 | $544K | Buy |
1,338
+200
| +18% | +$81.4K | 0.04% | 137 |
|
|
2023
Q3 | $396K | Sell |
1,138
-2
| -0.2% | -$695 | 0.04% | 140 |
|
|
2023
Q2 | $401K | Sell |
1,140
-223
| -16% | -$78.5K | 0.04% | 143 |
|
|
2023
Q1 | $429K | Buy |
1,363
+25
| +2% | +$7.88K | 0.04% | 134 |
|
|
2022
Q4 | $386K | Sell |
1,338
-49
| -4% | -$14.2K | 0.04% | 140 |
|
|
2022
Q3 | $402K | Buy |
1,387
+40
| +3% | +$11.6K | 0.04% | 135 |
|
|
2022
Q2 | $380K | Sell |
1,347
-524
| -28% | -$148K | 0.04% | 143 |
|
|
2022
Q1 | $488K | Buy |
1,871
+302
| +19% | +$78.8K | 0.04% | 148 |
|
|
2021
Q4 | $345K | Sell |
1,569
-403
| -20% | -$88.6K | 0.03% | 181 |
|
|
2021
Q3 | $358K | Hold |
1,972
| – | – | 0.03% | 158 |
|
|
2021
Q2 | $398K | Buy |
+1,972
| New | +$398K | 0.03% | 155 |
|
|
2020
Q4 | $467K | Sell |
1,977
-11
| -0.6% | -$2.6K | 0.05% | 144 |
|
|
2020
Q3 | $541K | Buy |
+1,988
| New | +$541K | 0.06% | 147 |
|